Given the significant clinical burden of concurrent HF and LC, and the lack of clearly defined molecular connections, we employed integrative bioinformatics to identify CYP4B1 as a key comorbidity gene (Fig 1). This evidence concerns the gene CYP4B1 and laryngotracheoesophageal cleft.